{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:43:48Z","timestamp":1791600228003,"version":"4.3.4"},"reference-count":55,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1136\/jnnp-2016-314956","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T20:30:57Z","timestamp":1488400257000},"page":"402-411","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":122,"title":["Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"88","author":[{"given":"Stella Andrea","family":"Glasmacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Nigel","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romi Anirban","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"key-10.1136\/jnnp-2016-314956-1","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"key-10.1136\/jnnp-2016-314956-2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1212\/WNL.38.7.1031","article-title":"Prevalence and natural history of progressive supranuclear palsy","volume":"38","author":"Golbe","year":"1988","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","article-title":"Incidence of progressive supranuclear palsy and multiple system atrophy in olmsted County, Minnesota, 1976 to 1990","volume":"49","author":"Bower","year":"1997","journal-title":"Neurology"},{"issue":"Pt 7","key":"key-10.1136\/jnnp-2016-314956-4","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/brain\/124.7.1438","article-title":"The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK","volume":"124","author":"Nath","year":"2001","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314956-5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J Neurol Sci"},{"issue":"Pt 12","key":"key-10.1136\/jnnp-2016-314956-6","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","article-title":"The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations","volume":"127","author":"Ozawa","year":"2004","journal-title":"Brain"},{"issue":"Pt 6","key":"key-10.1136\/jnnp-2016-314956-7","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314956-8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"163","author":"Gilman","year":"1999","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2016-314956-9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022293","article-title":"Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS-Parkinson Plus Scale","volume":"6","author":"Payan","year":"2011","journal-title":"PLoS One"},{"key":"key-10.1136\/jnnp-2016-314956-10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.parkreldis.2013.06.014","article-title":"Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients","volume":"19","author":"dell'Aquila","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.1136\/jnnp-2016-314956-13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2967\/jnumed.115.159822","article-title":"18F-FDG PET is an early predictor of overall survival in suspected atypical parkinsonism","volume":"56","author":"Hellwig","year":"2015","journal-title":"J Nucl Med"},{"key":"key-10.1136\/jnnp-2016-314956-14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/brain\/awn291","article-title":"Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study","volume":"132","author":"Bensimon","year":"2009","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314956-15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","article-title":"Natural history of multiple system atrophy in the USA: a prospective cohort study","volume":"14","author":"Low","year":"2015","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314956-16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","article-title":"The natural history of multiple system atrophy: a prospective european cohort study","volume":"12","author":"Wenning","year":"2013","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314956-17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/awf117","article-title":"Progression and prognosis in multiple system atrophy: an analysis of 230 japanese patients","volume":"125","author":"Watanabe","year":"2002","journal-title":"Brain"},{"issue":"Pt 12","key":"key-10.1136\/jnnp-2016-314956-18","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1093\/brain\/awv274","article-title":"Clinical features and autonomic testing predict survival in multiple system atrophy","volume":"138","author":"Coon","year":"2015","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314956-19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2016-314956-20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/awn065","article-title":"Clinical outcomes of progressive supranuclear palsy and multiple system atrophy","volume":"131","author":"O'Sullivan","year":"2008","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314956-21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/WNL.48.2.384","article-title":"Survival of patients with pathologically proven multiple system atrophy: a meta-analysis","volume":"48","author":"Ben-Shlomo","year":"1997","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-22","first-page":"128","volume-title":"Epidemiology","volume":"22","author":"Moher","year":"2011"},{"key":"key-10.1136\/jnnp-2016-314956-23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.1136\/jnnp-2016-314956-24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clinical research ed)"},{"key":"key-10.1136\/jnnp-2016-314956-25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"key-10.1136\/jnnp-2016-314956-26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.10211","article-title":"Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases","volume":"17","author":"Birdi","year":"2002","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2016-314956-27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jnnp.2009.195719","article-title":"Survival in progressive supranuclear palsy and frontotemporal dementia","volume":"81","author":"Chiu","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314956-28","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/brain\/awm032","article-title":"A clinical rating scale for progressive supranuclear palsy","volume":"130","author":"Golbe","year":"2007","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314956-29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/01.wnl.0000267643.24870.26","article-title":"Frontal presentation in progressive supranuclear palsy","volume":"69","author":"Donker Kaat","year":"2007","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/jnnp.60.6.615","article-title":"Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study","volume":"60","author":"Litvan","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314956-31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/WNL.57.1.138","article-title":"Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy","volume":"57","author":"Litvan","year":"2001","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/WNL.36.7.1005","article-title":"The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)","volume":"36","author":"Maher","year":"1986","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-33","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1212\/01.WNL.0000052991.70149.68","article-title":"Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study","volume":"60","author":"Nath","year":"2003","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-34","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1212\/WNL.50.6.1637","article-title":"Progressive supranuclear palsy: a survey of the disease course","volume":"50","author":"Santacruz","year":"1998","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/mds.25927","article-title":"Multiple system atrophy: prognostic indicators of survival","volume":"29","author":"Figueroa","year":"2014","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2016-314956-36","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1212\/WNL.0000000000002086","article-title":"Survival in synucleinopathies","volume":"85","author":"Goldstein","year":"2015","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314956-37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mds.23580","article-title":"Survival of korean patients with multiple system atrophy","volume":"26","author":"Kim","year":"2011","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2016-314956-38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/121.4.589","article-title":"The natural history of degenerative ataxia: a retrospective study in 466 patients","volume":"121 (Pt 4)","author":"Klockgether","year":"1998","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314956-39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0035-3787(07)90355-0","article-title":"Multiple system atrophy: Prognostic factors in the 'MSA- Aquitaine' cohort [French] Atrophie multisystematisee: Survie et facteurs pronostiques dans la cohorte\u00a0<<MSA-Aquitaine>>","volume":"163","author":"Krim","year":"2007","journal-title":"Rev Neurol"},{"key":"key-10.1136\/jnnp-2016-314956-40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/lary.24402","article-title":"Vocal fold motion impairment in multiple system atrophy","volume":"124","author":"Lalich","year":"2014","journal-title":"Laryngoscope"},{"key":"key-10.1136\/jnnp-2016-314956-41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00702-013-1133-7","article-title":"Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival","volume":"121","author":"Roncevic","year":"2014","journal-title":"J Neural Transm"},{"key":"key-10.1136\/jnnp-2016-314956-42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2169\/internalmedicine.33.321","article-title":"Survival of patients with multiple system atrophy","volume":"33","author":"Saito","year":"1994","journal-title":"Intern Med"},{"key":"key-10.1136\/jnnp-2016-314956-43","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12311-015-0668-6","article-title":"Epidemiology of multiple system Atrophy in Hokkaido, the Northernmost Island of Japan","volume":"14","author":"Sakushima","year":"2015","journal-title":"Cerebellum"},{"key":"key-10.1136\/jnnp-2016-314956-44","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/jnnp.57.9.1047","article-title":"Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT","volume":"57","author":"Schulz","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314956-45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L","article-title":"Stridor and death in multiple system atrophy","volume":"15","author":"Silber","year":"2000","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2016-314956-46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archneur.64.2.256","article-title":"Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy","volume":"64","author":"Tada","year":"2007","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2016-314956-47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00868999","article-title":"Survival in multiple system atrophy: a study of prognostic factors in 59 cases","volume":"243","author":"Testa","year":"1996","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314956-48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. an analysis of 100 cases","volume":"117 (Pt 4)","author":"Wenning","year":"1994","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314956-49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000069077","article-title":"Laryngeal stridor in multiple system atrophy","volume":"49","author":"Yamaguchi","year":"2003","journal-title":"Eur Neurol"},{"key":"key-10.1136\/jnnp-2016-314956-50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.parkreldis.2011.02.002","article-title":"Serum urate levels are not associated with survival in multiple system atrophy","volume":"17","author":"Kim","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.1136\/jnnp-2016-314956-51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.21839","article-title":"Survival in multiple system atrophy","volume":"23","author":"Schrag","year":"2008","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2016-314956-52","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00415-014-7384-x","article-title":"Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study","volume":"261","author":"Jecmenica-Lukic","year":"2014","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314956-53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s100720100021","article-title":"Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy","volume":"22","author":"Testa","year":"2001","journal-title":"Neurol Sci"},{"key":"key-10.1136\/jnnp-2016-314956-54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3233\/JPD-2012-11056","article-title":"Difference in MSA phenotype distribution between populations: genetics or environment?","volume":"2","author":"Ozawa","year":"2012","journal-title":"J Parkinsons Dis"},{"key":"key-10.1136\/jnnp-2016-314956-55","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s10072-013-1470-1","article-title":"Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue?","volume":"34","author":"Calandra-Buonaura","year":"2013","journal-title":"Neurol Sci"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2016-314956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:56:18Z","timestamp":1601697378000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2016-314956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,8]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1136\/jnnp-2016-314956"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2016-314956","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]}}}